DarioHealth Corp. Line of Credit Facility, Maximum Borrowing Capacity
DarioHealth Corp. (DRIO) had Line of Credit Facility, Maximum Borrowing Capacity of $25.00 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2024-03-28
- 2023-03-31: Line of Credit Facility, Maximum Borrowing Capacity $25.00M.
- 2022-06-09: Line of Credit Facility, Maximum Borrowing Capacity $50.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2023-03-31 | $25.00M 10-Q · filed 2023-05-11 |
| 2022-06-09 | $50.00M 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |